General Information of the Ferroptosis Regulator (ID: REG10419)
Regulator Name Elongation of very long chain fatty acids protein 6 (ELOVL6)
Synonyms
3-keto acyl-CoA synthase ELOVL6 {|HAMAP-Rule:MF_03206}; ELOVL fatty acid elongase 6 {|HAMAP-Rule:MF_03206}; Fatty acid elongase 2; Fatty acyl-CoA elongase; Long-chain fatty-acyl elongase; Very long chain 3-ketoacyl-CoA synthase 6 {|HAMAP-Rule:MF_03206}; Very long chain 3-oxoacyl-CoA synthase 6 {|HAMAP-Rule:MF_03206}
    Click to Show/Hide
Gene Name ELOVL6
Gene ID 79071
Regulator Type Protein coding
Uniprot ID Q9H5J4
Sequence
MNMSVLTLQEYEFEKQFNENEAIQWMQENWKKSFLFSALYAAFIFGGRHLMNKRAKFELR
KPLVLWSLTLAVFSIFGALRTGAYMVYILMTKGLKQSVCDQGFYNGPVSKFWAYAFVLSK
APELGDTIFIILRKQKLIFLHWYHHITVLLYSWYSYKDMVAGGGWFMTMNYGVHAVMYSY
YALRAAGFRVSRKFAMFITLSQITQMLMGCVVNYLVFCWMQHDQCHSHFQNIFWSSLMYL
SYLVLFCHFFFEAYIGKMRKTTKAE

    Click to Show/Hide
Family ELO family
Function
Catalyzes the first and rate-limiting reaction of the four reactions that constitute the long-chain fatty acids elongation cycle. This endoplasmic reticulum-bound enzymatic process allows the addition of 2 carbons to the chain of long- and very long-chain fatty acids (VLCFAs) per cycle. Condensing enzyme that elongates fatty acids with 12, 14 and 16 carbons with higher activity toward C16:0 acyl-CoAs. Catalyzes the synthesis of unsaturated C16 long chain fatty acids and, to a lesser extent, C18:0 and those with low desaturation degree. May participate in the production of saturated and monounsaturated VLCFAs of different chain lengths that are involved in multiple biological processes as precursors of membrane lipids and lipid mediators. { |HAMAP-Rule:MF_03206, }.

    Click to Show/Hide
HGNC ID
HGNC:15829
KEGG ID hsa:79071
Full List of the Ferroptosis Target of This Regulator and Corresponding Disease/Drug Response(s)
ELOVL6 can regulate the following target(s), and cause disease/drug response(s). You can browse detail information of target(s) or disease/drug response(s).
Browse Target
Browse Disease
Browse Drug
Long-chain-fatty-acid--CoA ligase 4 (ACSL4) [Driver]
In total 1 item(s) under this target
Experiment 1 Reporting the Ferroptosis Target of This Regulator [1]
Target for Ferroptosis Driver
Responsed Disease Colorectal cancer ICD-11: 2B91
Responsed Drug Apatinib Investigative
Pathway Response Fatty acid metabolism hsa01212
Ferroptosis hsa04216
Cell Process Cell ferroptosis
Cell proliferation
In Vitro Model
HCT 116 cells Colon carcinoma Homo sapiens CVCL_0291
HIEC-6 cells Normal Homo sapiens CVCL_6C21
Response regulation ACSL4, a vital regulator of ferroptosis, could interact with ELOVL6 directly. Apatinib promoted ferroptosis in colorectal cancer (CRC) cells by targeting ELOVL6/ACSL4, providing a new mechanism support for apatinib application in the clinical treatment of CRC.
Colorectal cancer [ICD-11: 2B91]
In total 1 item(s) under this disease
Experiment 1 Reporting the Ferroptosis-centered Disease Response [1]
Target Regulator Elongation of very long chain fatty acids protein 6 (ELOVL6) Protein coding
Responsed Drug Apatinib Investigative
Pathway Response Fatty acid metabolism hsa01212
Ferroptosis hsa04216
Cell Process Cell ferroptosis
Cell proliferation
In Vitro Model
HCT 116 cells Colon carcinoma Homo sapiens CVCL_0291
HIEC-6 cells Normal Homo sapiens CVCL_6C21
Response regulation ACSL4, a vital regulator of ferroptosis, could interact with ELOVL6 directly. Apatinib promoted ferroptosis in colorectal cancer (CRC) cells by targeting ELOVL6/ACSL4, providing a new mechanism support for apatinib application in the clinical treatment of CRC.
Apatinib [Investigative]
In total 1 item(s) under this drug
Experiment 1 Reporting the Ferroptosis-centered Drug Response [1]
Drug for Ferroptosis Inducer
Response Target Long-chain-fatty-acid--CoA ligase 4 (ACSL4) Driver
Responsed Disease Colorectal cancer ICD-11: 2B91
Pathway Response Fatty acid metabolism hsa01212
Ferroptosis hsa04216
Cell Process Cell ferroptosis
Cell proliferation
In Vitro Model
HCT 116 cells Colon carcinoma Homo sapiens CVCL_0291
HIEC-6 cells Normal Homo sapiens CVCL_6C21
Response regulation ACSL4, a vital regulator of ferroptosis, could interact with ELOVL6 directly. Apatinib promoted ferroptosis in colorectal cancer (CRC) cells by targeting ELOVL6/ACSL4, providing a new mechanism support for apatinib application in the clinical treatment of CRC.
References
Ref 1 Apatinib Promotes Ferroptosis in Colorectal Cancer Cells by Targeting ELOVL6/ACSL4 Signaling. Cancer Manag Res. 2021 Feb 11;13:1333-1342. doi: 10.2147/CMAR.S274631. eCollection 2021.